View moreMorepen Laboratories Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Morepen Laboratories Ltd
MOREPENLAB
Price Chart
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Key Metrics
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Morepen Laboratories Limited is a pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC).
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Torrent Pharmaceuticals Ltd
Gland Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 2.20%
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Morepen Laboratories Ltd leads gainers in ‘A’ group
2 days ago•Business Standard
Morepen Laboratories Q4: Net profit plunges 55% to Rs 12 cr, total income up to Rs 371 cr
1 month ago•Free Press Journal
Morepen Q4: Net profit falls 55% to Rs 12 cr, total income up to Rs 371 cr
1 month ago•Business Standard
Recent EventsAll events
Resignation
Morepen Laboratories Limited has informed the Exchange about resignation of Mrs. Anju Suri as Non Executive - Non Independent Director of the company w.e.f. 22-Jun-2022 | Download
Morepen Laboratories Limited has informed the Exchange about resignation of Mrs. Anju Suri as Non Executive - Non Independent Director of the company w.e.f. 22-Jun-2022 | Download
Conversion
Morepen Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held today i.e., Friday, 27th day of May, 2022 (commenced at 05:00 P.M. and concluded at 06:00 P.M.), inter-alia, approved the allotment of 2,13,42,505 Equity Shares of Rs. 2/- each, at an issue price of Rs. 53.72 per share, pursuant to the conversion of 1,14,65,201, 0.01% Compulsorily Convertible Preference Shares (￢ﾀﾘCCPS￢ﾀﾙ) of Rs. 100/- each. | Download
Morepen Laboratories Limited has informed the Exchange that the Board of Directors at their meeting held today i.e., Friday, 27th day of May, 2022 (commenced at 05:00 P.M. and concluded at 06:00 P.M.), inter-alia, approved the allotment of 2,13,42,505 Equity Shares of Rs. 2/- each, at an issue price of Rs. 53.72 per share, pursuant to the conversion of 1,14,65,201, 0.01% Compulsorily Convertible Preference Shares (￢ﾀﾘCCPS￢ﾀﾙ) of Rs. 100/- each. | Download
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data